Market Intelligence

The definitive data hub for Washington DC's cannabis industry — ABCA metrics, equity analysis, regulatory history, and market trends.

ABCA Official

Year:

Total Sales (Period)

$159.0M

9.1%vs prior month

Registered Patients

104K

4.7%vs prior month

Active Dispensaries

ABCA-licensed

Data Months

monthly reports

Revenue Trend

Total medical cannabis sales by month

Patient Growth

Active registered patients

Active Dispensaries

ABCA-licensed operators by month

Key Market Insights

Auto-generated from ABCA data — 10 insights

Annual Revenue Growth

+79.3%

Market Nearly Doubled in 12 Months

Total market revenue grew from $0.5M in 2024 to $0.9M in 2025 — a 79% annual growth rate. This makes DC one of the fastest-growing medical cannabis markets in the country.

Monthly New Self-Certs

+801.7%

Self-Cert Program: 9× Growth in Monthly Registrations

Monthly new self-certifications surged from 1,542 in Jan 2024 to a peak of 13,904 in Apr 2025 — a 802% increase. The cumulative pool crossed 100,000 patients in early 2025 and reached 170,628 by year-end.

Manufacturer Revenue Growth

+189.9%

Manufacturing Revenue: The Fastest-Growing Segment

Licensed manufacturer sales grew 190% YoY — from $0.1M in 2024 to $0.2M in 2025. This reflects the maturation of DC's supply chain as more manufacturers entered the market post-2024 regulatory expansion.

Record Monthly Revenue

All-Time Record: $0.17M in Dec 2023

Dec 2023 set the all-time monthly revenue record at $0.17M — driven by spring tourism and early market expansion.

Seasonal Revenue Pattern

Seasonality: Dec Peaks, Feb Dips

Across all years, Dec averages the highest monthly revenue ($0.09M) while Feb is consistently the weakest month ($0.05M avg). Dispensaries should plan promotions and inventory accordingly.

Patient Utilization Rate

-31.9%

Patient Utilization Rate: 31% of Registered Patients Shop Monthly

In Feb 2026, 32,740 of 104,433 registered patients made a purchase — a 31% utilization rate. This is down from 63% in Jan 2022, indicating a growing pool of registered-but-inactive patients.

Revenue Per Patient

-66.7%

Revenue Per Patient Visit: $2 (-67% vs 2022)

Average dispensary revenue per patient served was $2 in Feb 2026, compared to $6 in Jan 2022. Declining basket sizes may reflect increased price competition or a shift toward lower-cost products.

MD+VA Reciprocity Share

Maryland + Virginia = 80% of All Out-of-State Patients

MD and VA together account for 80% of all reciprocity patient visits. Maryland leads with 33,913 cumulative visits, followed by Virginia at 61,668. Florida, Pennsylvania, and New Jersey round out the top 5, reflecting DC's tourism draw from the Eastern Seaboard.

Fastest Product Growth

+241.9%

Vape Cartridge: Fastest-Growing Product Category (+242% YoY)

Vape Cartridge sales grew 242% from 2024 to 2025 — from $3057K to $10451K annually. Dispensaries stocking this category are well-positioned to capture growing consumer demand.

Consecutive Growth Months

Longest Consecutive Growth Streak: 6 Months

The market sustained 6 consecutive months of revenue growth — a sign of structural demand expansion rather than seasonal spikes. This streak was driven by the self-cert program's rapid patient acquisition phase in early-to-mid 2025.

DC Market Context

Key facts about Washington DC's medical cannabis program

ABCA Regulated

The Alcoholic Beverage and Cannabis Administration (ABCA) oversees all licensed medical dispensaries in DC. All sales data flows through their monthly program reports.

Medical Only (Licensed)

DC has licensed medical dispensaries under ABCA. Recreational gifting exists under Initiative 71 but is separate from the licensed market tracked here.

Monthly Reporting

ABCA publishes monthly Medical Cannabis Program (MCP) reports covering sales, patient counts, caregiver registrations, and dispensary activity.

8 Wards

DC's 8 wards show significant disparity in dispensary access. Wards 2 and 3 (Northwest) have the highest concentration; Wards 7 and 8 are underserved.